CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 

Merck And Co Inc 's Total Debt to Equity

MRK's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to net new borrowings of 0.56%, Total Debt to Equity fell to 0.93, above the Merck And Co Inc 's average Total Debt to Equity.

Within Major Pharmaceutical Preparations industry in the forth quarter 2023, 22 other companies have achieved lower Total Debt to Equity than Merck And Co Inc in the IV Quarter 2023. While Total Debt to Equity total ranking has deteriorated compared to the third quarter 2023 from 745 to 796 .

Explain Debt to Equity Ratio?
What is the structure of MRK´s Total Debt?
How valuable is the MRK´s Equity?


MRK Total Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -18.29 % -7.24 % -10.56 % 14.53 % 20.39 %
Y / Y Total Debt Change 14.22 % 14.6 % 16.57 % -3.3 % -7.28 %
Total Debt to Equity MRQ 0.93 0.84 0.95 0.66 0.67
MRK's Total Ranking # 796 # 745 # 1186 # 2252 # 650
Seq. Equity Change -8.87 % 6.6 % -17.4 % 1.84 % 3.45 %
Seq. Total Debt Change 0.56 % -5.56 % 20.05 % 0.18 % 0.9 %



Total Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 77
Overall Market # 796


Total Debt to Equity Statistics
High Average Low
1.25 0.57 0.22
(Dec 31 2020)   (March 31, 2008)




Financial Statements
Merck And Co Inc 's Equity $ 37,635 Millions Visit MRK's Balance sheet
Merck And Co Inc 's Total Debt $ 35,055 Millions Visit MRK's Balance sheet
Source of MRK's Sales Visit MRK's Sales by Geography


Cumulative Merck And Co Inc 's Total Debt to Equity

MRK's Total Debt to Equity for the trailling 12 Months

MRK Total Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -18.29 % -7.24 % -10.56 % 14.53 % 20.39 %
Y / Y Total Debt TTM Growth 14.22 % 14.6 % 16.57 % -3.3 % -7.28 %
Total Debt to Equity TTM 0.84 0.77 0.73 0.68 0.71
Total Ranking TTM # 29 # 105 # 2716 # 185 # 1963
Seq. Equity TTM Growth -8.87 % 6.6 % -17.4 % 1.84 % 3.45 %
Seq. Total Debt TTM Growth 0.56 % -5.56 % 20.05 % 0.18 % 0.9 %


On the trailing twelve months basis Due to the net new borrowings of 0.56% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeTotal Debt to Equity improved to 0.84, above the Merck And Co Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 3, during the past 12 months, other companies have achieved lower Total Debt to Equity than Merck And Co Inc . While Total Debt to Equity total ranking has improved so far to 29, from total ranking in previous 12 month period at 105.

Explain Debt to Equity Ratio?
What is the structure of MRK´s Total Debt?
How valuable is the MRK´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 7
Within the Market # 29


trailing twelve months Total Debt to Equity Statistics
High Average Low
1.12 0.49 0.03
(Mar 31 2021)  




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquityDec 31 2023 MRQ Total DebtDec 31 2023 MRQ Equity
Teva Pharmaceutical Industries Limited  2.44 $ 19,833.000  Millions$ 8,126.000  Millions
Amicus Therapeutics inc   2.42 $ 387.858  Millions$ 160.174  Millions
Eli Lilly And Company  2.32 $ 25,225.300  Millions$ 10,863.700  Millions
Arcutis Biotherapeutics Inc   2.28 $ 201.799  Millions$ 88.667  Millions
Blueprint Medicines Corporation  2.13 $ 278.011  Millions$ 130.609  Millions
Travere Therapeutics Inc   1.88 $ 377.263  Millions$ 200.810  Millions
Phibro Animal Health Corporation  1.75 $ 474.898  Millions$ 270.803  Millions
Ionis Pharmaceuticals Inc  1.68 $ 648.453  Millions$ 386.686  Millions
Eyenovia inc   1.59 $ 14.287  Millions$ 8.999  Millions
Jazz Pharmaceuticals Plc  1.53 $ 5,712.942  Millions$ 3,736.997  Millions
G1 Therapeutics Inc   1.46 $ 51.557  Millions$ 35.386  Millions
Xoma Corporation  1.40 $ 124.061  Millions$ 88.721  Millions
Alimera Sciences Inc   1.40 $ 64.489  Millions$ 46.170  Millions
Biovie Inc   1.36 $ 10.195  Millions$ 7.491  Millions
Catalent Inc   1.36 $ 5,005.000  Millions$ 3,687.000  Millions
Bristol myers Squibb Company  1.35 $ 39,772.000  Millions$ 29,485.000  Millions
Emergent Biosolutions Inc   1.32 $ 860.200  Millions$ 649.300  Millions
Zoetis Inc   1.32 $ 6,567.000  Millions$ 4,991.000  Millions
Soligenix inc   1.29 $ 3.261  Millions$ 2.522  Millions
Summit Therapeutics Inc   1.29 $ 100.000  Millions$ 77.692  Millions
Clene Inc   1.23 $ 16.521  Millions$ 13.390  Millions
Lexicon Pharmaceuticals Inc   1.07 $ 99.508  Millions$ 93.110  Millions
Merck and Co Inc   0.93 $ 35,055.000  Millions$ 37,635.000  Millions
Elanco Animal Health Inc  0.93 $ 5,774.000  Millions$ 6,223.000  Millions
Pds Biotechnology Corp  0.91 $ 23.673  Millions$ 26.131  Millions
Viatris Inc   0.89 $ 18,131.500  Millions$ 20,467.400  Millions
Perrigo Company Plc  0.85 $ 4,073.400  Millions$ 4,767.900  Millions
Ocular Therapeutix Inc   0.82 $ 74.925  Millions$ 91.131  Millions
Biofrontera Inc   0.81 $ 3.904  Millions$ 4.793  Millions
Pfizer Inc  0.81 $ 71,888.000  Millions$ 89,288.000  Millions

Date modified: 2024-02-27T10:48:35+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com